SCHEMBL30032225

SCHEMBL30032225

Cc1ccc(C(=O)Nc2ccc(CN3CCN(CCO)CC3)c(C(F)(F)F)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 4/20 0.66
▸ BRAF P15056 9/20 0.64
▸ EGFR P00533 7/20 0.61
▸ ABL1 P00519 6/20 0.61
▸ JAK2 O60674 1/20 0.61
▸ RET P07949 1/20 0.61
▸ PDGFRB P09619 1/20 0.61
▸ FGFR1 P11362 1/20 0.61
▸ SRC P12931 1/20 0.61
▸ PDGFRA P16234 1/20 0.61
▸ FLT1 P17948 1/20 0.61
▸ FGFR2 P21802 1/20 0.61
▸ FGFR4 P22455 1/20 0.61
▸ FGFR3 P22607 1/20 0.61
▸ JAK1 P23458 1/20 0.61
▸ CCNE1 P24864 1/20 0.61
▸ CDK2 P24941 1/20 0.61
▸ EPHA2 P29317 1/20 0.61
▸ EPHA3 P29320 1/20 0.61
▸ FLT4 P35916 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14318406 0.92 KIT (0.77) KITBRAFEGFRABL1
SCHEMBL29562197 0.92 KIT (0.77) KITBRAFEGFRABL1
Hydrochloric Acid SCHEMBL29833672 0.91 KIT (0.75) KITBRAFEGFRABL1
SCHEMBL28054362 0.90 HTT (0.65) KITBRAF
SCHEMBL590507 0.88 KIT (0.86) KITBRAFEGFRABL1JAK2
SCHEMBL27997207 0.87 KIT (0.61) KITBRAFEGFRABL1
SCHEMBL17664555 0.85 KIT (0.74) KITBRAFEGFRABL1
SCHEMBL29629475 0.85 KIT (0.60) KITBRAFEGFRABL1
SCHEMBL16755299 0.85 KIT (0.87) KITBRAFEGFRABL1JAK2
SCHEMBL29562470 0.82 BRAF (0.82) KITBRAFEGFRABL1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279759-A 3- ((8- ((1H-pyrazol-4-yl) amino) imidazo [1,2-a ] pyridin-3-yl) ethynyl) -N-phenylbenzamide derivative, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient 大邱庆北尖端医疗产业振兴财团 2022-11-01 — — CN claimed
CN-115279759-A 3- ((8- ((1H-pyrazol-4-yl) amino) imidazo [1,2-a ] pyridin-3-yl) ethynyl) -N-phenylbenzamide derivative, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient 大邱庆北尖端医疗产业振兴财团 2022-11-01 — — CN disclosed
Send feedback